Skip to main content

Year: 2022

Plug Provides 2022 Revenue Expectations Update Reflecting Potential Timing and Supply Chain Impact

Demand and Pipeline Remains Robust LATHAM, N.Y., Oct. 14, 2022 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of turnkey hydrogen solutions for the global green hydrogen economy, provides revenue expectations update for 2022. The company believes that its prior full year 2022 revenue guidance of $900-$925M could be 5% -10% lower for the year. The revenue impact reflects some larger projects potentially being completed in 2023 instead of 2022 due to timing and broader supply chain issues. While revenue could be lower than previously anticipated in 2022, demand for the fuel cell applications and electrolyzer business remains robust. The Company recently became aware of the potential impact to its full year 2022 revenue and believes it is prudent to update stakeholders. It is important to note that the company...

Continue reading

Decision adopted in the Extraordinary General Meeting of Shareholders of AB Amber Grid

At the Extraordinary General Meeting of Shareholders of AB Amber Grid (legal entity code 303090867, office address Laisvės pr. 10, LT-04215 Vilnius, Republic of Lithuania) on 14 October 2022 decision was adopted regarding the approval of the conclusion of procurement contracts for the reconstruction of sections of the gas pipeline Vilnius – Kaunas. Contracts will be concluded when all approvals, decisions and necessary procedures required for the signing and execution of the contracts have been obtained or completed, as required by the Articles of Association of AB Amber Grid and relevant legal acts of the Republic of Lithuania. The following decision was adopted at the Extraordinary General Meeting of Shareholders AB Amber Grid: 1. Regarding approval of AB Amber Grid Board’s decision of 20 September 2022 (minutes No. VLD-19) Decision...

Continue reading

Walmart to Expand Sales of Biomerica’s Aware® Breast Self Exam; Product will now be available in over 2400 Walmart stores

Simple at-home device to increase sensitivity in breast self-exams Early detection of breast cancer saves lives About 80% of breast cancer is detected by women themselves who notice changes in their breastIRVINE, Calif., Oct. 14, 2022 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that under a General Merchandise Supplier Agreement with Walmart, the Company’s Aware® Breast Self Exam device will now be sold in over 2400 Walmart’s retail stores. In July, the Company announced that Walmart had begun selling the Aware product online through Walmart.com. Walmart has now determined to also sell Aware in-store, at approximately 50% of their retail store locations. Biomerica has received and shipped an Initial stocking order from Walmart, and the product should be on store shelves within weeks. The...

Continue reading

Smart for Life Featured by New to the Street

Interviews to Air on National Television Including Bloomberg and Fox Business MIAMI, Oct. 14, 2022 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide announced that a series of interviews hosted by New to the Street featuring A.J. Cervantes, Jr., Founder and Chairman, and Darren Minton, Chief Executive Officer will begin airing on national television, including Bloomberg and Fox Business. “Having completed five material acquisitions in just the last year alone, there are significant ongoing corporate developments, and we are honored that Smart for Life will be featured in a series of interviews hosted by New to the Street that will air on national television....

Continue reading

Todos Medical CLIA/CAP Lab Provista Submits Emergency Use Authorization Application for MonkeyPox PCR Test to US FDA

New York, NY, and Tel Aviv, ISRAEL, Oct. 14, 2022 (GLOBE NEWSWIRE) — via NewMediaWire —Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified clinical laboratory Provista Diagnostics has filed an Emergency Use Authorization (EUA) application with the US Food & Drug Administration (FDA) for its PCR MonkeyPox Test. The EUA application was submitted for lesion-based PCR. The sensitivity achieved for the currently available lesion-based laboratory-developed test (LDT) is 0.95 viral copies per reaction (0.095 copies/ul). “The submission of this EUA application underscores our commitment to providing best-in-class PCR-based testing for emerging infectious diseases,” said Gerald E. Commissiong, President & CEO of Todos Medical and...

Continue reading

Turbine Oil Market is projected to reach $1.91 Billion by 2030 Globally, at a CAGR of 3.9%, says MarketsandMarkets™

Chicago, Oct. 14, 2022 (GLOBE NEWSWIRE) — The global Turbine Oil Market is projected to reach USD 1.91 billion by 2030, at a CAGR of 3.9% from USD 1.40 billion in 2022, as per the recent study by MarketsandMarkets™. Turbine oils are being promoted by a number of manufacturers for use in a wide variety of equipment, including air compressors, vacuum pumps, and bearings. These elements are anticipated to have a substantial impact on the growth of the turbine oil market globally. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21842248 Browse in-depth TOC on “Turbine oil Market”254 – Market Data Tables 65 – Figures List of Key Players in Turbine oil Market: Royal Dutch Shell (Netherlands)ExxonMobil Corporation (US)BP plc (UK)TotalEnergies SE (US)Chevron Corporation (US)Idemitsu Kosan...

Continue reading

Regarding the sale of the shares of the joint stock company “Pieno logistika” belonging to AB Vilkyškių pieninė to another Vilvi Group company UAB “Kelmės pienas”

AB “Pieno logistika”, belonging to Vilvi group, was founded in 2013; its main activity is the rental of buildings. Until now, 58.9 shares of the company (218,781 units) belonged to AB Vilkyškių pieninė. In  2022 October 13 AB Vilkyškių pieninė sells the shares of AB “Pieno logistika” to another group company UAB “Kelmės pienas”. The decision to sell shares has been made on purpose to continue ensuring further reorganization of activities of Vilvi Group’s individual companies in order to attain operational efficiency, optimization and diversification. Additional information will be provided by: Director General Gintaras Bertašius Phone: +370 441 55 330

Continue reading

ArrowMark Financial Corp. Announces Estimated September 2022 Net Asset Value and Sets Date to Host the Third Fiscal Quarter 2022 Earnings Conference Call

DENVER, Oct. 14, 2022 (GLOBE NEWSWIRE) — ArrowMark Financial Corp., (NASDAQ: BANX) (“ArrowMark Financial” or the “Company”), today announced that the Company’s September 30, 2022, estimated and unaudited Net Asset Value (“NAV”) was $20.74 per share. This NAV reflects the regular third quarter cash dividend of $0.39 per share, paid on September 29, 2022. ArrowMark Financial will host a conference call for investors and other interested parties beginning at 5:00 p.m. (Eastern Time) on Wednesday, November 9, 2022, to report on the Company’s financial results and investment performance and provide its current market views on bank-related assets. The call will be hosted by Sanjai Bhonsle, Chairman and Chief Executive Officer, Dana Staggs, President and Patrick Farrell, Chief Financial Officer. The conference call will be accessible...

Continue reading

Veterinary Pain Management Market worth $2.5 billion by 2027 – Exclusive Report by MarketsandMarkets™

Chicago, Oct. 14, 2022 (GLOBE NEWSWIRE) — Veterinary Pain Management Market is projected to grow from USD 1.8 billion in 2022 to USD 2.5 billion by 2027, at a CAGR of 6.7% from 2022 to 2027, according to a new report by MarketsandMarkets™. The Pain is the physiological term to describe the chemical processes that are at work in the body that receive a stimulus, modify it, and transfer it to the brain for interpretation and reaction. The stimulus can be physical, temperature, chemical, or inflammatory damage to tissues. In veterinary practices, pain management is achieved through analgesic drugs and devices. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96167677 Browse in-depth TOC on “Veterinary Pain Management Market”299 – Tables56 – Figures298 – Pages In this report, the veterinary pain...

Continue reading

Electric Construction Equipment Market worth $24.8 billion by 2027 – Exclusive Report by MarketsandMarkets™

Chicago, Oct. 14, 2022 (GLOBE NEWSWIRE) — Electric Construction Equipment Market is estimated to grow from USD 9.2 billion in 2022 to USD 24.8 billion by 2027 at a CAGR of 22.0% over the forecast period, according to a new report by MarketsandMarkets™. The increasing demand to minimize exhaust emissions, ventilation costs in underground mining and preference for the low noise construction machines in residential areas would create growth opportunities for the Electric Construction Equipment Market. Browse in-depth TOC on “Electric Construction Equipment Market”331 – Tables58 – Figures 342 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=129288251 The mining equipment would hold the largest market share among the electric off-highway equipment types The mining application segment is currently...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.